Transgender Youth Experiences with Implantable GnRH Agonists for Puberty Suppression
- PMID: 36033209
- PMCID: PMC9398484
- DOI: 10.1089/trgh.2021.0006
Transgender Youth Experiences with Implantable GnRH Agonists for Puberty Suppression
Abstract
This descriptive study reports caregiver experiences with GnRH agonist implants among a cohort of youth followed in a pediatric hospital-based gender clinic. We administered a survey to 36 of 55 eligible caregivers ascertaining demographics and satisfaction, with a medical record review of any surgical complications. The overwhelming majority (97.1%) reported satisfaction with the procedure and would undergo the implant procedure again (94.4%). The most frequent challenges noted were about affordability (39.8%) and insurance denials (39.8%). Implantable GnRH agonist can be used successfully in pediatric patients with gender dysphoria. Future policy should seek to address concerns regarding insurance approval and reimbursement.
Keywords: implant; insurance; patient satisfaction; puberty blockers; transgender youth.
Copyright 2022, Mary Ann Liebert, Inc., publishers.
Conflict of interest statement
No competing financial interests exist.
Figures
Similar articles
-
Histrelin Implants for Suppression of Puberty in Youth with Gender Dysphoria: A Comparison of 50 mcg/Day (Vantas) and 65 mcg/Day (SupprelinLA).Transgend Health. 2021 Feb 15;6(1):36-42. doi: 10.1089/trgh.2020.0055. eCollection 2021 Feb. Transgend Health. 2021. PMID: 33644320 Free PMC article.
-
Youth and Caregiver Perspectives on Barriers to Gender-Affirming Health Care for Transgender Youth.J Adolesc Health. 2016 Sep;59(3):254-261. doi: 10.1016/j.jadohealth.2016.03.017. Epub 2016 May 24. J Adolesc Health. 2016. PMID: 27235374
-
Mental Health Concerns and Insurance Denials Among Transgender Adolescents.LGBT Health. 2017 Jun;4(3):188-193. doi: 10.1089/lgbt.2016.0151. Epub 2017 Apr 12. LGBT Health. 2017. PMID: 28402749
-
Transgender medicine - puberty suppression.Rev Endocr Metab Disord. 2018 Sep;19(3):221-225. doi: 10.1007/s11154-018-9457-0. Rev Endocr Metab Disord. 2018. PMID: 30112593 Review.
-
Transgender youth: current concepts.Ann Pediatr Endocrinol Metab. 2016 Dec;21(4):185-192. doi: 10.6065/apem.2016.21.4.185. Epub 2016 Dec 31. Ann Pediatr Endocrinol Metab. 2016. PMID: 28164070 Free PMC article. Review.
Cited by
-
Implementation of Patient-Reported Outcome Measures for Gender-Affirming Care Worldwide: A Systematic Review.JAMA Netw Open. 2023 Apr 3;6(4):e236425. doi: 10.1001/jamanetworkopen.2023.6425. JAMA Netw Open. 2023. PMID: 37010869 Free PMC article.
References
-
- Definitions. Trans Student Educational Resources. 2019. Available at www.transstudent.org/definitions Accessed November 16, 2020.
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association, 2013.
-
- Vrouenraets LJJJ, Fredriks AM, Hannema SE, et al. . Early medical treatment of children and adolescents with gender dysphoria: an empirical ethical study. J Adolesc Health. 2015;57:367–373. - PubMed
-
- Vance SR, Ehrensaft D, Rosenthal SM. Psychological and medical care of gender nonconforming youth. Pediatrics. 2014;134:1184–1192. - PubMed
-
- De Vries ALC, McGuire JK, Steensma TD, et al. . Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics. 2014;134:696–704. - PubMed
LinkOut - more resources
Full Text Sources